US District Court rules in favor of Watson in generic Mucinex patent infringement suit
Links shared publicly online about this topic.
- 517total visits
US District Court rules in favor of Watson in generic Mucinex patent infringement suit
View full resource at news-medical.net
Tags: Pharma, Health Insurance, Medicare, Watson Pharmaceuticals, News
Most Recently Shared on February 10, 2011 at 9:36 am By:
Medicare News: US District Court rules in favor of Watson in generic Mucinex patent infringement suit: Watson Ph... http://bit.ly/gWM4Pn
U.S. District Court rules in favor of Watson over Mucinex patent suit
news-medical.net — “Watson Pharmaceuticals, Inc. today confirmed that the United States Court of Appeals for the Federal Circuit has affirmed the United States District Court for the Southern District of Florida's February 2011 decision that Watson's generic versions of Mucinex(R), Mucinex(R) D, and Mucinex(R) DM Extended-Release products do not infringe U.S. Patent No. 6,372,252.” View full resource at news-medical.net
Most Recently Shared on July 8, 2011 at 5:04 am By:
U.S. District Court rules in favor of Watson over Mucinex patent suit: Watson Pharmaceuticals, Inc. today confir... http://bit.ly/o4uqGR
U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit
news-medical.net — “Watson Pharmaceuticals, Inc., a leading integrated global pharmaceutical company, today confirmed that it has received a favorable decision from the U.S. Court of Appeals for the Federal Circuit related to its ongoing patent challenge in connection with Watson's Abbreviated New Drug Application seeking FDA approval to market a generic version of Teva Women's Health, Inc.'s SEASONIQUE and ethinyl estradiol.” View full resource at news-medical.net
Most Recently Shared on March 28, 2011 at 10:15 am By:
Pregnancy News: U.S. District Court rules in favor of Watson in generic SEASONIQUE patent infringement suit: Wat... http://bit.ly/eQS7t6
Advertisement
